Literature DB >> 18333238

Efficacy of antibiotic penetration into pancreatic necrosis.

W Otto1, K Komorzycki, M Krawczyk.   

Abstract

BACKGROUND: Infection of pancreatic necrosis is the most dangerous complication of acute necrotizing pancreatitis. Infection is undoubtedly caused by the endogenous flora of the host. This is why prophylaxis with a broad-spectrum antibiotic is considered an effective procedure. However, two aspects should be taken into consideration when choosing the antibiotic; it should have the spectrum of action consistent with the pathogens and it should penetrate effectively to the necrotic tissue of the pancreas. The aim of the study was to estimate the efficacy of piperacillin/tazobactam penetration into pancreatic necrosis in patients who received intravenous infusion of piperacillin/tazobactam at a dose of 4.5 g every 8 h for 14-21 days, as the prophylaxis in the treatment of acute necrotizing pancreatitis. PATIENTS AND METHODS: Necrotic tissue of the pancreas and the inflammatory ascites surrounding the pancreas were derived from 15 patients (male, 10; female, 5; mean age 46 years), who underwent laparatomy due to pancreatic necrosis after treatment for 14-21 days. Tissue/fluid samples were investigated for the concentration of the antibiotic by fluoroscopic/spectroscopic methods of registration in an HPLC system.
RESULTS: The mean concentration of piperacillin/tazobactam was established as 120 mg/kg (SD+/-34) in the necrotic pancreatic tissue and as 183 mg/kg (SD+/-37) in the inflammatory pancreatic ascites.
CONCLUSIONS: In patients with acute necrotizing pancreatitis, the study indicates effective penetration of piperacillin/tazobactam to the necrotic pancreatic tissue and to the inflammatory ascites surrounding the pancreas.

Entities:  

Year:  2006        PMID: 18333238      PMCID: PMC2131372          DOI: 10.1080/13651820500467275

Source DB:  PubMed          Journal:  HPB (Oxford)        ISSN: 1365-182X            Impact factor:   3.647


  22 in total

Review 1.  Acute pancreatitis.

Authors:  W Steinberg; S Tenner
Journal:  N Engl J Med       Date:  1994-04-28       Impact factor: 91.245

Review 2.  Infected pancreatic necrosis.

Authors:  C Bassi
Journal:  Int J Pancreatol       Date:  1994-08

3.  Cost efficacy of tazobactam/piperacillin versus imipenem/cilastatin in the treatment of intra-abdominal infection.

Authors:  E S Dietrich; B Schubert; W Ebner; F Daschner
Journal:  Pharmacoeconomics       Date:  2001-01       Impact factor: 4.981

Review 4.  Infection prevention in necrotizing pancreatitis: an old challenge with new perspectives.

Authors:  G Butturini; R Salvia; R Bettini; M Falconi; P Pederzoli; C Bassi
Journal:  J Hosp Infect       Date:  2001-09       Impact factor: 3.926

Review 5.  Natural history of acute pancreatitis and the role of infection.

Authors:  R Isenmann; H G Beger
Journal:  Baillieres Best Pract Res Clin Gastroenterol       Date:  1999-07

Review 6.  Role of the gut in the course of severe acute pancreatitis.

Authors:  Basil J Ammori
Journal:  Pancreas       Date:  2003-03       Impact factor: 3.327

7.  A randomized multicenter clinical trial of antibiotic prophylaxis of septic complications in acute necrotizing pancreatitis with imipenem.

Authors:  P Pederzoli; C Bassi; S Vesentini; A Campedelli
Journal:  Surg Gynecol Obstet       Date:  1993-05

8.  Penetration of clindamycin, cefoxitin, and piperacillin into pancreatic juice in man.

Authors:  C Brattström; A S Malmborg; G Tydén
Journal:  Surgery       Date:  1988-05       Impact factor: 3.982

Review 9.  Gastrointestinal disorders of the critically ill. Bacterial translocation in the gut.

Authors:  Reiner Wiest; Heiko C Rath
Journal:  Best Pract Res Clin Gastroenterol       Date:  2003-06       Impact factor: 3.043

10.  Early antibiotic treatment in acute necrotising pancreatitis.

Authors:  V Sainio; E Kemppainen; P Puolakkainen; M Taavitsainen; L Kivisaari; V Valtonen; R Haapiainen; T Schröder; E Kivilaakso
Journal:  Lancet       Date:  1995-09-09       Impact factor: 79.321

View more
  4 in total

1.  Effects of prophylactic antibiotics in acute pancreatitis.

Authors:  Povilas Ignatavicius; Astra Vitkauskiene; Juozas Pundzius; Zilvinas Dambrauskas; Giedrius Barauskas
Journal:  HPB (Oxford)       Date:  2012-04-01       Impact factor: 3.647

2.  Piperacillin-tazobactam penetration into human pancreatic juice.

Authors:  Elisa Bertazzoni Minelli; Anna Benini; Luigina Franco; Claudio Bassi; Paolo Pederzoli
Journal:  Antimicrob Agents Chemother       Date:  2008-09-22       Impact factor: 5.191

Review 3.  2019 WSES guidelines for the management of severe acute pancreatitis.

Authors:  Ari Leppäniemi; Matti Tolonen; Antonio Tarasconi; Helmut Segovia-Lohse; Emiliano Gamberini; Andrew W Kirkpatrick; Chad G Ball; Neil Parry; Massimo Sartelli; Daan Wolbrink; Harry van Goor; Gianluca Baiocchi; Luca Ansaloni; Walter Biffl; Federico Coccolini; Salomone Di Saverio; Yoram Kluger; Ernest Moore; Fausto Catena
Journal:  World J Emerg Surg       Date:  2019-06-13       Impact factor: 5.469

Review 4.  Diagnosis and Treatment of Acute Pancreatitis.

Authors:  Julia Walkowska; Nicol Zielinska; R Shane Tubbs; Michał Podgórski; Justyna Dłubek-Ruxer; Łukasz Olewnik
Journal:  Diagnostics (Basel)       Date:  2022-08-15
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.